[{"Assets_0_Q3_USD":59146000000.0,"CommonStockSharesOutstanding_0_Q3_shares":1266000000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":6564000000.0,"NetIncomeLoss_1_Q3_USD":-1165000000.0,"NetIncomeLoss_3_Q3_USD":2690000000.0,"StockholdersEquity_0_Q3_USD":20604000000.0,"EarningsPerShareBasic_1_Q3_USD":-0.92,"EarningsPerShareBasic_3_Q3_USD":2.12,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":1267000000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":1271000000.0,"Ticker":"GILD","CIK":"882095","name":"GILEAD SCIENCES INC","OfficialName":"Gilead Sciences Inc. Common Stock","form":"10-Q","period":"20190930","fy":"2019.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"78838305412.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"SP500","filed":"20191105"}]